Group 1 - The Hong Kong Stock Connect Innovative Drug ETF (159570) experienced a decline of 2.29% on September 17, with a trading volume of 3.846 billion yuan [1] - The ETF's shares increased by 96 million, bringing the total shares to 11.038 billion, with a total increase of 2.769 billion shares over the last 20 trading days [1] - The latest net asset value of the ETF is calculated to be 21.696 billion yuan [1] Group 2 - The performance benchmark for the ETF is the National Index of Hong Kong Stock Connect Innovative Drugs, adjusted for valuation exchange rates [1] - The fund is managed by E Fund Management Co., Ltd., with the fund manager being Le Wuqiong [1] - Since its inception on December 28, 2023, the ETF has returned 96.56%, while the return over the past month is -2.19% [1]
9月17日港股通创新药ETF（159570）份额增加9600.00万份
Xin Lang Cai Jing·2025-09-18 01:11